一场主题为“中国生物医药新基建与生物药高质量发展”的圆桌对话，邀请上下游企业代表各抒己见，尝试为产业未来发展，叩问路在何方。
Time：
2023-05-22 09:28
Author：
写意君
江山代有才人出，各领风骚数百年。放眼当下，以科伦药业、丽珠集团、信立泰、海思科等颈部创新药企业已经脱颖而出，站在时代的浪潮中勇往直前。
Time：
2023-05-21 12:32
Author：
陶秋聘
2023年2月，中国国家药监局药品审评中心（CDE）将滨会生物申报的重组人GM-CSF溶瘤II型单纯疱疹病毒（OH2）注射液（Vero细胞）纳入了突破性治疗品种。
Time：
2023-05-11 09:10
Author：
xieyijun
随着人们用眼负担加重和老龄化趋势的发展，眼科疾病的患病人数呈现上升趋势，眼健康问题在现代社会尤为突出，是社会日益关注的焦点问题。
Time：
2023-05-10 09:28
Author：
十七
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务